Hyten John E.
Known title: DirectorCIK: 0002040511
Associated companies
Transaction History
| AI | ▼ Sell | Other | 2,500 | $27K | 9/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $25K | 8/14/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $23K | 7/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $28K | 6/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $22K | 5/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $24K | 4/15/2026 | View on chart |
| AI | ▼ Sell | Gift | 43,944 | $0 | 3/31/2026 | View on chart |
| AI | ▼ Sell | Gift | 43,944 | $0 | 3/31/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $22K | 3/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $27K | 2/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $34K | 1/15/2026 | View on chart |
| AI | ▼ Sell | Other | 2,500 | $37K | 12/15/2025 | View on chart |
| AI | ▼ Sell | Gift | 4,999 | $0 | 6/25/2025 | View on chart |
| AI | ▼ Sell | Gift | 43,943 | $0 | 6/16/2025 | View on chart |
| AI | ▼ Sell | Gift | 43,943 | $0 | 6/16/2025 | View on chart |
| AI | ▼ Sell | Open Market | 10,000 | $238K | 6/13/2025 | View on chart |
| AI | ▼ Sell | Gift | 5,000 | $0 | 3/4/2025 | View on chart |
| AI | ▼ Sell | Open Market | 5,000 | $192K | 12/12/2024 | View on chart |
| AI | ▼ Sell | Gift | 7,800 | $0 | 12/12/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
C3.ai Gets Mixed Analyst Ratings and Attention
C3.ai received conflicting analyst views this week, with Northland Capital Markets upgrading the stock to Outperform while UBS noted it needs more quarters to stabilize. The stock is currently trading near its 52-week high, significantly above the average analyst target of $8.90. This divergence in opinions highlights the uncertainty surrounding the company's future performance despite recent price strength.
C3.ai Gets Mixed Analyst Ratings and Attention. C3.ai received conflicting analyst views this week, with Northland Capital Markets upgrading the stock to Outperform while UBS noted it needs more quarters to stabilize. The stock is currently trading near its 52-week high, significantly above the average analyst target of $8.90. This divergence in opinions highlights the uncertainty surrounding the company's future performance despite recent price strength.